Composite inpatient healthcare supply may retain exemption despite MRP medicine billing, while separate taxable sale characterisation remains disputed...
Working-capital adjustment determines whether software-services transfer-pricing margins fall within the statutory tolerance range, eliminating any ad...
Permanent establishment deductions upheld for expatriate salaries, direct costs and trading losses, while head-office costs require fresh classificati...
The SEBI Amendment Regulations, 2025 modify the Alternative Investment Funds (AIF) regulatory framework, specifically amending Regulation 17. The amendment clarifies that Category II AIFs shall invest in investee companies or units of Category I or other Category II AIFs as disclosed in the Placement Memorandum. The regulation introduces an explanatory clause specifying that such funds shall primarily invest in unlisted securities and/or listed debt securities rated 'A' or below, either directly or through units of other Alternative Investment Funds, in a manner prescribed by the regulatory board. The amendment aims to provide greater clarity and guidance for investment strategies of Category II Alternative Investment Funds.
The SEBI Amendment Regulations, 2025 modify the Alternative Investment Funds (AIF) regulatory framework, specifically amending Regulation 17. The amendment clarifies that Category II AIFs shall invest in investee companies or units of Category I or other Category II AIFs as disclosed in the Placement Memorandum. The regulation introduces an explanatory clause specifying that such funds shall primarily invest in unlisted securities and/or listed debt securities rated 'A' or below, either directly or through units of other Alternative Investment Funds, in a manner prescribed by the regulatory board. The amendment aims to provide greater clarity and guidance for investment strategies of Category II Alternative Investment Funds.
Note: It is a system-generated summary and is for quick reference only.